11504964 · Active · incorporated 8 years, 2 months ago · Norwich
Biotech Biotech & Life Sciences Drug Discovery Medical Devices Series A
Ikarovec is a pre-clinical phase gene therapy company developing treatments for common eye diseases to restore sight and prevent blindness.
Ikarovec Limited is a private limited company registered at Companies House under number 11504964, incorporated on 7 August 2018, with a registered office in Norwich. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 59 filings for this company, including 2 funding rounds. Its most recent round closed in October 2024, raising £5m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 2 | Oct 2024 | £5m | £41.00 |
| Round 1 | Jun 2020 | £2.5m | £41.00 |
Showing the 10 most recent of 59 filings.
See the complete cap table with every shareholder, founder tags, dilution across 9 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.